Kuros Biosciences (CHIX:KURNZ) Selling and Marketing Expense : CHF26.30 Mil (TTM As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Kuros Biosciences Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Kuros Biosciences's Selling and Marketing Expense for the six months ended in Jun. 2024 was CHF18.49 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was CHF26.30 Mil.

Kuros Biosciences Selling and Marketing Expense Historical Data

The historical data trend for Kuros Biosciences's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Selling and Marketing Expense Chart

Kuros Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Selling and Marketing Expense

Get a 7-Day Free Trial

1.03

2.26

4.80

8.08

17.13

Kuros Biosciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Selling and Marketing Expense	Get a 7-Day Free Trial															5.43	2.66	9.33	7.80	18.49

Kuros Biosciences Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF26.30 Mil.

Kuros Biosciences Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (CHIX:KURNz) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

CSBTF:USA 0RHR:UK KURN:Switzerland

Address

Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website

https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences Headlines

No Headlines